It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy,...
Vous n'êtes pas connecté
Ludwig Cancer Research scientists have devised new types of chimaeric antigen-receptor (CAR) T cells—a type of cancer immunotherapy—that can be switched on to varying degrees of intensity and then switched off on demand with existing drugs. The design and preclinical evaluation of the CAR-T cells, led by Melita Irving and Greta Maria Paola Giordano Attianese [...]
It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy,...
Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic...
Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumours use to cripple immune cells and impede their attack—blocking the...
SPRING, Texas, Nov. 08, 2024 (GLOBE NEWSWIRE) — Io Therapeutics, Inc., presented results from studies done in breast, colorectal, and prostate...
Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...
As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Exhausted T cells -; which have lost...
Immunotherapies that mobilise a patient’s immune system to fight cancer have become a treatment pillar. These therapies, including CAR T-cell...
Elsewhere in the region, Slovak PM hails ‘successful’ China visit; ‘Czech Trump’ revels in return of The Donald; and Trump’s victory...
The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual...
A new imaging technique could mean patients with aggressive brain tumours benefit from cutting-edge immunotherapy treatments, according to...